美国研究综述-苹果、EverQuote、联合健康

Reuters2024-12-26

((自动化翻译由路透提供，请见免责声明 ))

路透12月26日 - 华尔街证券分析师周四调整了对苹果、EverQuote 和 UnitedHealth 等多家美国上市公司的评级和目标价。

要闻

* 苹果公司：Wedbush将目标价从300美元上调至325美元

* EverQuote Inc ：雷蒙德-詹姆斯（Raymond James）将目标价从 "跑赢大盘 "上调至 "强烈买入"。

* Progressive Corp ：雷蒙德-詹姆斯将公司评级从 "跑赢大盘 "上调至 "跑赢大盘"。

* Rapt Therapeutics Inc ：H.C. Wainwright 将评级从中性上调至买入

* UnitedHealth ：雷蒙德-詹姆斯（Raymond James）将该股列入分析师当前最爱名单

以下是路透周四报导的美国公司研究行动摘要。股票条目按字母顺序排列。

* ACV Auctions Inc ：Needham将目标价从26美元上调至28美元

* Anavex Life Sciences Corp ：H.C. Wainwright 将目标价从 40 美元上调至 42 美元

* 苹果公司：Wedbush将目标价从300美元上调至325美元

* EverQuote Inc ：Raymond James将目标价从 "跑赢大盘 "上调至 "强烈买入"。

* Hagerty Inc ：雷蒙德-詹姆斯将其评级从 "市场表现 "下调至 "表现不佳"。

* Kemper Corp ：雷蒙德-詹姆斯将目标价从75美元上调至82美元

* Palvella Therapeutics Inc：H.C. Wainwright给予买入评级

* Progressive Corp ：Raymond James将其评级从 "市场表现 "上调至 "跑赢大盘"。

* Rapt Therapeutics Inc ：H.C. Wainwright将其评级从中性上调至买入

* Surgery Partners Inc ：Benchmark 将目标价从 50 美元下调至 40 美元

* UnitedHealth ：雷蒙德-詹姆斯（Raymond James）将该股列入分析师当前最爱名单

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/2494585747?lang=zh_CN&edition=full","thumbnail":"","is_english":false,"pubTime":"2024-12-26 21:03","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2494585747","market":"us","top_or_hot":-1,"title":"美国研究综述-苹果、EverQuote、联合健康","media":"Reuters","content":"<html><body><p>((自动化翻译由路透提供，请见免责声明 ))</p><p>    路透12月26日 - 华尔街证券分析师周四调整了对<a href=\"https://laohu8.com/S/AAPL\">苹果</a>、EverQuote 和 UnitedHealth 等多家美国上市公司的评级和目标价。 </p><p>要闻 </p><p> * 苹果公司  ：Wedbush将目标价从300美元上调至325美元</p><p> * EverQuote Inc   ：雷蒙德-詹姆斯（Raymond James）将目标价从 \"跑赢大盘 \"上调至 \"强烈买入\"。</p><p> * Progressive Corp   ：雷蒙德-詹姆斯将公司评级从 \"跑赢大盘 \"上调至 \"跑赢大盘\"。</p><p> * Rapt <a href=\"https://laohu8.com/S/LENZ\">Therapeutics</a> Inc   ：H<a href=\"https://laohu8.com/S/02403\">.C</a>. Wainwright 将评级从中性上调至买入</p><p> * UnitedHealth   ：雷蒙德-詹姆斯（Raymond James）将该股列入分析师当前最爱名单</p><p> 以下是路透周四报导的美国公司研究行动摘要。股票条目按字母顺序排列。</p><p> * ACV Auctions Inc   ：Needham将目标价从26美元上调至28美元</p><p> * Anavex Life Sciences Corp   ：H.C. Wainwright 将目标价从 40 美元上调至 42 美元</p><p> * 苹果公司  ：Wedbush将目标价从300美元上调至325美元</p><p> * EverQuote Inc   ：Raymond James将目标价从 \"跑赢大盘 \"上调至 \"强烈买入\"。</p><p> * <a href=\"https://laohu8.com/S/HGTY\">Hagerty</a> Inc   ：雷蒙德-詹姆斯将其评级从 \"市场表现 \"下调至 \"表现不佳\"。</p><p> * <a href=\"https://laohu8.com/S/KMPB\">Kemper Corp</a>   ：雷蒙德-詹姆斯将目标价从75美元上调至82美元</p><p> * <a href=\"https://laohu8.com/S/PVLA\">Palvella Therapeutics</a> Inc：H.C. Wainwright给予买入评级</p><p> * Progressive Corp   ：Raymond James将其评级从 \"市场表现 \"上调至 \"跑赢大盘\"。</p><p> * Rapt Therapeutics Inc   ：H.C. Wainwright将其评级从中性上调至买入</p><p> * Surgery Partners Inc   ：Benchmark 将目标价从 50 美元下调至 40 美元</p><p> * UnitedHealth   ：雷蒙德-詹姆斯（Raymond James）将该股列入分析师当前最爱名单</p></body></html>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>美国研究综述-苹果、EverQuote、联合健康</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n美国研究综述-苹果、EverQuote、联合健康\n</h2>\n\n<h4 class=\"meta\">\n\n\n2024-12-26 21:03 北京时间&nbsp;&nbsp;&nbsp;<a href=https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1><strong>Reuters</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>((自动化翻译由路透提供，请见免责声明 ))    路透12月26日 - 华尔街证券分析师周四调整了对苹果、EverQuote 和 UnitedHealth 等多家美国上市公司的评级和目标价。 要闻  * 苹果公司  ：Wedbush将目标价从300美元上调至325美元 * EverQuote Inc   ：雷蒙德-詹姆斯（Raymond James）将目标价从 \"跑赢大盘 \"上调至 \"强烈买入\"...</p>\n\n<a href=\"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"LU0820562030.AUD","symbol_name":"ALLIANZ INCOME AND GROWTH \"AMH2\" (AUDHDG) H2 INC","start_time":0,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","article_id":"2494585747","we_media_id":"1036604489","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2494585747","pubTimestamp":1735218224,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Reuters","introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"id":"1036604489","head_image":"https://static.tigerbbs.com/443ce19704621c837795676028cec868"},"summary":"    路透12月26日 - 华尔街证券分析师周四调整了对苹果、EverQuote 和 UnitedHealth 等多家美国上市公司的评级和目标价。要闻  * 苹果公司  ：Wedbush将目标价从300美元上调至325美元 * EverQuote Inc   ：雷蒙德-詹姆斯将目标价从 \"跑赢大盘 \"上调至 \"强烈买入\"。* Kemper Corp   ：雷蒙德-詹姆斯将目标价从75美元上调至82美元 * Palvella Therapeutics Inc：H.C. Wainwright给予买入评级 * Progressive Corp   ：Raymond James将其评级从 \"市场表现 \"上调至 \"跑赢大盘\"。","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"zh","relate_stocks":{"LU0820562030.AUD":"ALLIANZ INCOME AND GROWTH \"AMH2\" (AUDHDG) H2 INC","LU0203347892.USD":"SCHRODER ISF QEP GLOBAL ACTIVE VALLUE \"A\" (USD)  INC AV","BK4588":"碎股","LU1506573853.SGD":"MANULIFE GF GLOBAL EQUITY \"AA\" (SGD) INC","LU0175139822.USD":"AB FCP I Global Equity Blend A USD","LU0289960550.SGD":"AB FCP I - GLOBAL EQUITY BLEND PORTFOLIO 'A' (SGD) ACC","AAPL":"苹果","KMPR":"Kemper Corp","LU1235295455.SGD":"Fidelity Global Multi Asset Growth & Income A-ACC-SGD","LU2242650005.HKD":"FIDELITY FUNDS GLOBAL MULTI ASSET DYNAMIC \"A\" (HKD) ACC","HGTY":"Hagerty","UNH":"联合健康","LU0096362180.USD":"CT (LUX) I GLOBAL FOCUS \"DU\" (USD)","IE00B4R5TH58.HKD":"JANUS HENDERSON GLOBAL LIFE SCIENCES \"A2\" (HKD) ACC","ACVA":"ACV Auctions Inc.","SGXZ81514606.USD":"大华环球创新基金A Acc USD","PGR":"美国前进保险公司","LU1244550494.USD":"FRANKLIN GLOBAL MULTI-ASSET INCOME \"A\" (USDHEDGED) ACC","LU0256863902.USD":"ALLIANZ US EQUITY \"AT\" (USD) ACC","AVXL":"Anavex Life Sciences Corp.","SG9999002232.USD":"Allianz Global High Payout USD","LU0976567544.SGD":"FTIF - Templeton Global Income A Mdis SGD-H1","LU2360106780.USD":"BGF WORLD TECHNOLOGY \"A4\" (USD) INC","LU1839511570.USD":"WELLS FARGO GLOBAL FACTOR ENHANCED EQUITY \"I\" (USD) ACC","IE00B7SZL793.SGD":"Legg Mason Royce - US Small Cap Opportunity A Acc SGD-H","LU2087625088.SGD":"ALLSPRING  US ALL CAP GROWTH \"A\" (SGDHDG) ACC","SGRY":"Surgery Partners, Inc.","LU1670627923.USD":"M&G (LUX) NORTH AMERICAN DIVIDEND \"A\" (USD) ACC","LU1582987597.SGD":"M&G (LUX) INCOME ALLOCATION \"A-H\" (SGDHDG) INC","RAPT":"RAPT Therapeutics, Inc.","LU1642822529.SGD":"THREADNEEDLE (LUX) GLOBAL TECHNOLOGY \"A\" (SGD) ACC","LU0127658192.USD":"EASTSPRING INVESTMENTS GLOBAL TECHNOLOGY \"A\" (USD) ACC","LU0122379950.USD":"贝莱德世界健康科学A2","BK4532":"文艺复兴科技持仓","SG9999003800.SGD":"Nikko AM Global Dividend Equity Acc SGD-H","LU0672654240.SGD":"FTIF - Franklin US Opportunities A Acc SGD-H1","LU0345768740.USD":"NINETY ONE GSF GLOBAL STRATEGIC MANAGED \"A\" (USD) INC","IE0003U64NQ7.SGD":"PIMCO BALANCED INCOME AND GROWTH \"M\" (SGDHDG) ACC","LU0079474960.USD":"联博美国增长基金A","LU0029864427.USD":"TEMPLETON GLOBAL \"A\" (USD) INC","IE00B7KXQ091.USD":"Janus Henderson Balanced A Inc USD","LU2092937148.SGD":"Blackrock ESG Multi-Asset A8 SGD-H","LU1291159041.SGD":"CPR Invest - Global Silver Age A2 Acc SGD-H","EVER":"Everquote Inc.","LU0149725797.USD":"汇丰美国股市经济规模基金","LU2023250330.USD":"ALLIANZ INCOME AND GROWTH \"AMG\" (USD) INC","MACW.SI":"APPLE 3xLongSG261006","LU0820561818.USD":"安联收益及增长平衡基金Cl AM DIS","PVLA":"Palvella Therapeutics","LU2592432038.USD":"WELLINGTON MULTI-ASSET HIGH INCOME \"A\" (USD) ACC"},"translate_title":"U.S. Research Review-Apple, EverQuote, UnitedHealth","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"AAPL":1,"UNH":1,"ACVA":0.9,"SGRY":0.9,"RAPT":0.9,"PVLA":0.9,"PGR":0.9,"KMPR":0.9,"AVXL":0.9,"EVER":0.9,"HGTY":0.9,"MACW.SI":0.6},"content_text":"((自动化翻译由路透提供，请见免责声明 ))    路透12月26日 - 华尔街证券分析师周四调整了对苹果、EverQuote 和 UnitedHealth 等多家美国上市公司的评级和目标价。 要闻  * 苹果公司  ：Wedbush将目标价从300美元上调至325美元 * EverQuote Inc   ：雷蒙德-詹姆斯（Raymond James）将目标价从 \"跑赢大盘 \"上调至 \"强烈买入\"。 * Progressive Corp   ：雷蒙德-詹姆斯将公司评级从 \"跑赢大盘 \"上调至 \"跑赢大盘\"。 * Rapt Therapeutics Inc   ：H.C. Wainwright 将评级从中性上调至买入 * UnitedHealth   ：雷蒙德-詹姆斯（Raymond James）将该股列入分析师当前最爱名单 以下是路透周四报导的美国公司研究行动摘要。股票条目按字母顺序排列。 * ACV Auctions Inc   ：Needham将目标价从26美元上调至28美元 * Anavex Life Sciences Corp   ：H.C. Wainwright 将目标价从 40 美元上调至 42 美元 * 苹果公司  ：Wedbush将目标价从300美元上调至325美元 * EverQuote Inc   ：Raymond James将目标价从 \"跑赢大盘 \"上调至 \"强烈买入\"。 * Hagerty Inc   ：雷蒙德-詹姆斯将其评级从 \"市场表现 \"下调至 \"表现不佳\"。 * Kemper Corp   ：雷蒙德-詹姆斯将目标价从75美元上调至82美元 * Palvella Therapeutics Inc：H.C. Wainwright给予买入评级 * Progressive Corp   ：Raymond James将其评级从 \"市场表现 \"上调至 \"跑赢大盘\"。 * Rapt Therapeutics Inc   ：H.C. Wainwright将其评级从中性上调至买入 * Surgery Partners Inc   ：Benchmark 将目标价从 50 美元下调至 40 美元 * UnitedHealth   ：雷蒙德-詹姆斯（Raymond James）将该股列入分析师当前最爱名单","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":0},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":1,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.4","shortVersion":"4.29.4","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2494585747"}